The disease-modifying agents market refers to the segment of the pharmaceutical industry that focuses on developing drugs that can modify or slow down the progression of a disease. These agents are used to treat chronic diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and Alzheimer’s disease, among others. Disease-modifying agents work by targeting the underlying mechanisms of a disease, such […]